Rockwell Medical, Inc. (RMTI)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$6.98
-0.16%
Mkt Cap $35.57M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$2.00
Range $2.00 – $2.00
Implied Upside
-71.3%
Consensus $2.00 vs current $6.98